Members of the Team
- Alex Adusei Agyemang
- Susanne Grönlund
Info coming soon
Magnus is the head of preclinical research in the Neonatal Neuroprotection group. He is an Associate Professor (Docent) in Experimental Medical Research.
I conducted my PhD in the Antioxidation Medicine group, at the Department of Infection Medicine, Lund University on the topic ”A1M: Innate defense against pathological oxidation”.
After defending my PhD in 2009, I have had the opportunity to work in a strong and highly collaborative research environment within the field of experimental medical research. My work is focused on understanding molecular mechanisms responsible for development of human diseases or disease conditions, with a special emphasis and focus on neuroprotection of the immature brain. In my research, I have particularly focused on generating an understanding of disease development in order to develop new pharmaceutical strategies.
In addition to my academic research, I have been fortunate to work as chief scientific officer and head of preclinical development at the pharmaceutical company A1M Pharma/Guard Therapeutics International.
How do you find your true academic passion? Perhaps by being involved in multitude of research topics. Growing up in the west coast city Halmstad, Sweden, Niklas suddenly realized in his twenties how fascinating mathematics, chemistry and biology is. To be able to study at the University, Niklas needed to go to the Swedish school for adults (Komvux) for studying adequate courses for entering universitates programs. Soon thereafter, Niklas started to study Bioengineering at Lund University. There, passion grow to biology more and more. He realized, the only true mirror is knowledge. During the studies at Lund University, Niklas conducted an internship in Roy Wollmans lab at University of California, San Diego. The topic was system biology. Here, Niklas understood how stimulating the working at the academia is. After receiving a master’s in biotechnology with conducting a master thesis in Edgar Peras lab at stem cell center I Lund, his eyes opened for neurodevelopment by conducting experiments on Xenopus laevis embryos. Studying embryonic development was truly fascinating, however, it would take years before Niklas would start a PhD in neurodevelopment. Before this time was ripe, Niklas became an project assistant in microbiology where he won the honorary prize Lund University and Sparbanksstiftelsen Finn’s prize for developing a peptide to inhibit S.aures binding to hemoglobin. Reaching the iron capsulated in hemoglobin is paramount for S.aures survival in the circulation and infection of its host. Thereafter, accidently, and perhaps consequently, Niklas was introduced Professor David Ley. Now Niklas revived the opportunity to perform a PhD neonatal neuroprotection and he accepted.
I was born in 1985 in Espoo (Finland) with my identical twin sister; 4 weeks before our due date. I received a Bachelor of Health care – degree in Biomedical Laboratory Science in 2012 and graduated as a biomedical laboratory scientist from Metropolia University of Applied Science, Helsinki, Finland. Work in medical research felt like a vocation to me from the very beginning. I started my career at Folkhälsan Research Center in Helsinki in 2013 directly after my graduation. Just a year after that I did something surprising and moved abroad, to Lund, and joined the Neonatal Neuroprotection groups in 2014. I was supposed to stay only 6 months, but here I am still! Since then I have been working in our (pre-clinical) laboratory as a laboratory scientist (biomedicinks analytiker). I pay a lot of attention to high standards in the lab, which means that reliable data, traceability and transparency are the cornerstones of my work. I keep our lab running and have been called the heart and the Queen of the lab. I obey both titles! I was blessed with a relatively sharp mind and steady pipetting hand and I like to use both of them. I want to leave this world better and healthier than I found it, with a pipette as my tool.
Research Assistant, Helena Karlsson, has over two decade’s experience of preclinical work from industrial experience to University. Helena has worked at Astra Zeneca, Active Biotech and A1M Pharma (now Guard Therapeutics), and has broad experience in preclinical work from start to finish.
Amanda is a Postdoctoral Fellow focused on preclinical and clinical research in the Neonatal Neuroprotection group.
I conducted my PhD in the Antioxidation Medicine group, at the Department of Infection
Medicine, Lund University on the topic ”α 1 -microglobulin – Therapeutic opportunities in
kidney and erythrocyte pathology”. My PhD studies focused on understanding oxidative stress in development or as part of human disease in addition to how to counteract the
negative effects with antioxidants.
After defending my PhD in 2021, I continued my research in the field of systemic radiation therapy, primarily focusing on oxidative damage as a side effect of radiation therapy.
I joined the Neonatal Neuroprotection team in 2022. In the group my main focus is protection of the immature brain. My research is mainly focused on the negative effects of oxidative stress, hemoglobin and heme toxicity after intraventricular hemorrhage or other conditions affecting the immature brain.
Claes Ekström is a Research Engineer with an educational background in Biology and has a role in the NN-group as a project manager and coordinator of preclinical projects, both internal and external. Claes has over 15 years’ experience of applied research from the Biotech/Pharma industry, including in vivo method development and project management. Claes is also a Clinical Coordinator for the randomized multi-center clinical trial “Less is More” where he is managing the project team including all study sites communicating towards site investigators and team members.
Linda Nilsson is an intensive care nurse working at the Neonatal unit in Lund University Hospital since 2002. Except her clinical duty Linda has an assignment as a research nurse – a role with great variation that includes areas within planning and implementation of clinical trials, and also a coordinating role which combines patient care and external contacts.
Margareta Gebka is an intensive care nurse working at the Neonatal unit in Lund University Hospital since 2000. Except her clinical duty Margareta has an assignment as a research nurse – a role with great variation that includes areas within planning and implementation of clinical trials, and also a coordinating role which combines patient care and external contacts.
Info coming soon
Matteo Bruschettini is the Director of Cochrane Sweden. Matteo is a physician and an Associate Professor of Pediatrics. He is also a specialist in Neonatology, which is his main research area.
He has contributed to the Cochrane Collaboration since 2011 and is also a Cochrane trainer. Matteo has published more than 85 scientific papers, including 25 systematic Cochrane reviews.
According to Google Scholar, his work has been cited more than 2,300 times and his h-factor is 28.